EP
Eversept Partners’s Xenon Pharmaceuticals XENE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-155,540
| Closed | -$6.1M | – | 72 |
|
|
2024
Q4 | $6.1M | Buy |
+155,540
| New | +$6.1M | 0.54% | 34 |
|
|
2023
Q3 | – | Sell |
-171,378
| Closed | -$6.6M | – | 76 |
|
|
2023
Q2 | $6.6M | Sell |
171,378
-31,894
| -16% | -$1.23M | 0.55% | 32 |
|
|
2023
Q1 | $7.28M | Sell |
203,272
-72,432
| -26% | -$2.59M | 0.51% | 33 |
|
|
2022
Q4 | $10.9M | Buy |
275,704
+16,092
| +6% | +$635K | 0.95% | 22 |
|
|
2022
Q3 | $9.37M | Sell |
259,612
-206,299
| -44% | -$7.45M | 0.81% | 24 |
|
|
2022
Q2 | $14.2M | Buy |
465,911
+55,890
| +14% | +$1.7M | 1.01% | 26 |
|
|
2022
Q1 | $12.5M | Buy |
410,021
+200,502
| +96% | +$6.13M | 0.96% | 27 |
|
|
2021
Q4 | $6.55M | Buy |
+209,519
| New | +$6.55M | 0.42% | 47 |
|
|
2020
Q2 | – | Sell |
-71,591
| Closed | -$812K | – | 75 |
|
|
2020
Q1 | $812K | Sell |
71,591
-144,018
| -67% | -$1.63M | 0.2% | 44 |
|
|
2019
Q4 | $2.83M | Hold |
215,609
| – | – | 0.5% | 36 |
|
|
2019
Q3 | $1.94M | Sell |
215,609
-8,731
| -4% | -$78.7K | 0.6% | 35 |
|
|
2019
Q2 | $2.21M | Hold |
224,340
| – | – | 0.62% | 33 |
|
|
2019
Q1 | $2.28M | Buy |
224,340
+19,236
| +9% | +$195K | 0.66% | 28 |
|
|
2018
Q4 | $1.29M | Sell |
205,104
-4,635
| -2% | -$29.2K | 0.7% | 29 |
|
|
2018
Q3 | $2.77M | Buy |
+209,739
| New | +$2.77M | 1.22% | 17 |
|